{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-007595","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2023-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.195818+00:00","generated_at":"2026-06-14T07:26:08.319302+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Ra Medical Q1 net loss $66.4M, goodwill impaired $56.1M; revenue $85K","bullets":["Revenue of $85K vs $9K YoY; net loss $66.4M includes $56.1M goodwill impairment.","Cash used in operations $12.1M, incl. $5M DOJ settlement payment; cash $12.2M at Mar 31.","Acquisition of Catheter Precision closed Jan 2023; $8M financing obtained in March.","CEO Will McGuire resigned; David Jenkins named Interim CEO; Steve Passey appointed CFO.","VIVO system launch underway with five direct sales reps; LockeT closure device introduced."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-007595","json":"https://secwatch.observer/filing/0001654954-23-007595.json","markdown":"https://secwatch.observer/filing/0001654954-23-007595.md","text":"https://secwatch.observer/filing/0001654954-23-007595.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/0001654954-23-007595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/rmed_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T07:26:08.319302+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"47f438ee83ea2499b131a0f52e533847904b1eab","claim":"Catheter Precision, Inc. reported the three months ended March 31, 2023 results: revenue $85 thousand, net income net loss was $66.4 million.","evidence_excerpt":"Passey. · Announced the resignation of its CEO, and appointment of its new Interim CEO, David Jenkins, as of April 28, 2023. · Revenues for the quarter ended March 31, 2023 were $85 thousand, net loss was $66.4 million and cash used by operations was $12.1 million, which includes a $5.0 million cash payment associated with a legacy settlement. Accounting for the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/0001654954-23-007595-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2023"},{"label":"Revenue","value":"$85 thousand"},{"label":"Net income","value":"net loss was $66.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}